Skip to main content
. 2021 May 4;3(2):dlab057. doi: 10.1093/jacamr/dlab057

Table 2.

Delafloxacin and comparator activity against S. pneumoniae serotypes

Serotype/antibiotic MIC50 (mg/L) MIC90 (mg/L) MIC range (mg/L) Susceptible (%)
All S. pneumoniae serotypes (n = 142)
 Delafloxacin 0.015 0.015 0.004–0.03 100
 Moxifloxacin 0.25 0.25 0.06–0.25 100
 Azithromycin 0.25 >32 0.06–>32 76.1
 Penicillina ≤0.03 2 ≤0.03–4 71.8
 Clindamycin 0.06 >32 ≤0.015–>32 85.2
 Ceftriaxone 0.015 0.5 ≤0.008 100
S. pneumoniae serotype 3 (n = 27)
 Delafloxacin 0.015 0.03 0.008–0.03 100
 Moxifloxacin 0.25 0.25 0.12–0.25 100
 Azithromycin 0.12 0.25 0.06–0.25 100
 Penicillina ≤0.03 ≤0.03 ≤0.03–0.06 100
 Clindamycin 0.06 0.06 ≤0.015–0.12 100
 Ceftriaxone 0.015 0.015 ≤0.008–0.015 100
S. pneumoniae serotype 19F (n = 14)
 Delafloxacin 0.015 0.015 0.004–0.03 100
 Moxifloxacin 0.12 0.25 0.12–0.25 100
 Azithromycin 0.25 >32 0.12–>32 85.7
 Penicillina 0.25 2 ≤0.03–2 14.3
 Clindamycin 0.06 0.5 0.06–>32 85.7
 Ceftriaxone 0.06 0.5 0.015–1 100
S. pneumoniae serotype 23F (n = 10)
 Delafloxacin 0.015 0.015 0.004–0.015 100
 Moxifloxacin 0.12 0.25 0.06–0.25 100
 Azithromycin 2 >32 0.25–>32 40
 Penicillina ≤0.03 2 ≤0.03–2 50
 Clindamycin 0.06 >32 0.06–>32 80
 Ceftriaxone 0.12 1 0.015–1 100
a

CLSI oral penicillin breakpoints.20